Sharof M. Tugizov, DVM, PhD, DSc

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
tugizov_sharof

Professor, Department of Medicine, UCSF

sharof.tugizov@ucsf.edu

Phone: (415) 514-3177 (voice)
Box 0512, UCSF
San Francisco, CA 94143-0512

View on UCSF Profiles


Additional Websites


Education

Institute of Agriculture, School of Veterinary Medicine, Samarkand, Uzbekistan (former Soviet Union), DVM 1981, Veterinary Medicine
Institute of Experimental Veterinary Medicine and Ivanosky Institute of Virology, Moscow, Russia, PhD, 1985, Virology, Cell Biology
Ivanosky Institute of Virology, Russian Academy of Medical Sciences, Moscow, Russia, DSc, 1996, Medical Virology Infectious Disease


Professional Experience

  • 1985-88
    Junior Research Scientist, Dept. of Virus Physiology, Ivanovsky Institute of Virology, Academy of Medical Sciences, Moscow, USSR
  • 1988-91
    Senior Research Scientist, Dept. of Molecular Biology, Ivanovsky Institute of Virology, Academy of Medical Sciences, Moscow, USSR
  • 1991-94
    Visiting Scientist, Department of Stomatology, School of Dentistry, University of California, San Francisco, California
  • 1994-99
    Researcher in Virology and Molecular Biology, Department of Stomatology, School of Dentistry, University of California, San Francisco, California
  • 1999-2005
    Assistant Adjunct Professor, Department of Medicine, School of Medicine, University of California, San Francisco, California
  • 2005-11
    Associate Professor, Department of Medicine, School of Medicine, University of California, San Francisco, California
  • 2011-current
    Professor, Department of Medicine, School of Medicine, University of California, San Francisco, California

Honors & Awards

  • 2001 Hellman Fellow
  • Ad hoc reviewer for NIH, USA, 2006
  • Ad hoc reviewer for NIH, USA, 2009
  • Ad hoc reviewer for Cancer Research Institute, United Kingdom, 2002
  • Ad hoc reviewer for Cancer Research Institute, United Kingdom, 2006
  • Ad hoc reviewer for Cancer Research Institute, United Kingdom, 2009
  • Ad hoc reviewer for Hellman Family Foundation, 2010
  • Ad hoc referee for Journal of Virology, Journal of Dermatology, In vitro, Journal of Oral Pathology and Medicine, Voprosi Virusologii (in Russian), British Journal of Dermatology, Plos Pathogens, Virology, Journal of Dental Research, Chemotherapy, AIDS, Viral Immunology
  • Member of Editorial Board, Virology& Mycology

Selected Publications

  1. Sufiawati I, Tugizov SM. HIV-Associated Disruption of Tight and Adherens Junctions of Oral Epithelial Cells Facilitates HSV-1 Infection and Spread. PLoS One. 2014; 9(2):e88803.
    View on PubMed
  2. Tugizov SM, Herrera R, Chin-Hong P, Veluppillai P, Greenspan D, Michael Berry J, Pilcher CD, Shiboski CH, Jay N, Rubin M, Chein A, Palefsky JM. HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus. Virology. 2013 Nov; 446(1-2):378-88.
    View on PubMed
  3. Tugizov SM, Herrera R, Palefsky JM. Epstein-Barr virus transcytosis through polarized oral epithelial cells. J Virol. 2013 Jul; 87(14):8179-94.
    View on PubMed
  4. Tugizov SM, Herrera R, Veluppillai P, Greenspan D, Soros V, Greene WC, Levy JA, Palefsky JM. Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epithelia. J Virol. 2012 Mar; 86(5):2556-70.
    View on PubMed
  5. Challacombe SJ, Fidel PL, Tugizov S, Tao L, Wahl SM. HIV infection and specific mucosal immunity: workshop 4B. Adv Dent Res. 2011 Apr; 23(1):142-51.
    View on PubMed
  6. Tugizov SM, Webster-Cyriaque JY, Syrianen S, Chattopadyay A, Sroussi H, Zhang L, Kaushal A. Mechanisms of viral infections associated with HIV: workshop 2B. Adv Dent Res. 2011 Apr; 23(1):130-6.
    View on PubMed
  7. Weinberg A, Naglik JR, Kohli A, Tugizov SM, Fidel PL, Liu Y, Herzberg M. Innate immunity including epithelial and nonspecific host factors: workshop 1B. Adv Dent Res. 2011 Apr; 23(1):122-9.
    View on PubMed
  8. Tugizov SM, Herrera R, Veluppillai P, Greenspan D, Soros V, Greene WC, Levy JA, Palefsky JM. HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells. Virology. 2011 Jan 20; 409(2):211-22.
    View on PubMed
  9. Dorner M, Zucol F, Alessi D, Haerle SK, Bossart W, Weber M, Byland R, Bernasconi M, Berger C, Tugizov S, Speck RF, Nadal D. beta1 integrin expression increases susceptibility of memory B cells to Epstein-Barr virus infection. J Virol. 2010 Jul; 84(13):6667-77.
    View on PubMed
  10. Xiao J, Palefsky JM, Herrera R, Sunshine C, Tugizov SM. EBV-positive human sera contain antibodies against the EBV BMRF-2 protein. Virology. 2009 Oct 10; 393(1):151-9.
    View on PubMed
  11. Xiao J, Palefsky JM, Herrera R, Berline J, Tugizov SM. EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells. Virology. 2009 Jun 5; 388(2):335-43.
    View on PubMed
  12. Haga T, Uchide N, Tugizov S, Palefsky JM. Role of E-cadherin in the induction of apoptosis of HPV16-positive CaSki cervical cancer cells during multicellular tumor spheroid formation. Apoptosis. 2008 Jan; 13(1):97-108.
    View on PubMed
  13. Xiao J, Palefsky JM, Herrera R, Berline J, Tugizov SM. The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells. Virology. 2008 Jan 20; 370(2):430-42.
    View on PubMed
  14. Tugizov S, Herrera R, Veluppillai P, Greenspan J, Greenspan D, Palefsky JM. Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J Virol. 2007 Jun; 81(11):5484-96.
    View on PubMed
  15. Xiao J, Palefsky JM, Herrera R, Tugizov SM. Characterization of the Epstein-Barr virus glycoprotein BMRF-2. Virology. 2007 Mar 15; 359(2):382-96.
    View on PubMed
  16. Tugizov S, Berline J, Herrera R, Penaranda ME, Nakagawa M, Palefsky J. Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex. J Virol. 2005 Jan; 79(2):1099-112.
    View on PubMed
  17. Tugizov SM, Berline JW, Palefsky JM. Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med. 2003 Mar; 9(3):307-14.
    View on PubMed
  18. Tugizov S, Maidji E, Xiao J, Pereira L. An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membrane. J Virol. 1999 Oct; 73(10):8677-88.
    View on PubMed
  19. Tugizov S, Maidji E, Xiao J, Zheng Z, Pereira L. Human cytomegalovirus glycoprotein B contains autonomous determinants for vectorial targeting to apical membranes of polarized epithelial cells. J Virol. 1998 Sep; 72(9):7374-86.
    View on PubMed
  20. Maidji E, Tugizov S, Abenes G, Jones T, Pereira L. A novel human cytomegalovirus glycoprotein, gpUS9, which promotes cell-to-cell spread in polarized epithelial cells, colocalizes with the cytoskeletal proteins E-cadherin and F-actin. J Virol. 1998 Jul; 72(7):5717-27.
    View on PubMed

Go to UCSF Profiles, powered by CTSI